Tag: neutropenia

Latest News

New strategy identified to address the underlying cause of LAD1 patients' symptoms

Newsemia
Owing to a rare genetic mutation, individuals with leukocyte adhesion deficiency type 1 (LAD1) experience a suite of symptoms that trace back to an immune...
Latest News

Congenital Cytomegalovirus and Autoimmune Neutropenia: Cause or Coincidence?

Newsemia
Penner, J; Chan, CS-Y; Burns, JE; Ali, S; Lyall, H; (2020) Congenital Cytomegalovirus and Autoimmune Neutropenia: Cause or Coincidence? Pediatric Infectious Disease Journal 10.1097/INF.0000000000002583 ....
Latest News

FDA to decide on Spectrum Pharmaceuticals’ neutropenia drug by Oct. 2020

Newsemia
Spectrum said the FDA had accepted its application for Rolontis, which had shown non-inferiority to Amgen’s Neulasta in Phase III testing. However, oncologists expressed mixed...
Neurology

Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature

Newsemia
Ocrelizumab is a recombinant humanized monoclonal antibody approved for the treatment of multiple sclerosis (MS) directed against CD20, a membrane glycosylated protein expressed on B-lymphocytes,...
Pharma / Biotech

Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer.

Newsemia
Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer. Cancer Sci. 2019 Sep 10;: Authors: Makino Y, Makihara-Ando R,...
Neurology

PRAC Restricts Use of Alemtuzumab for MS Pending Ongoing Review

Newsemia
The EMA committee recommends updating the product information to note the potential for acute immune-mediated conditions, stroke, cervicocephalic arterial dissection, and severe neutropenia. News Alerts...
Pharma / Biotech

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.

Newsemia
Related Articles A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia. PLoS One. 2019;14(3):e0212837 Authors:...
Latest News

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Newsemia
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva®...
Latest News

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Newsemia
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia...
Gastroenterology

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Newsemia
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint. Source link...
Pharma / Biotech

PERJETA (Pertuzumab) Injection, Solution, Concentrate [Genentech, Inc.]

Newsemia
Updated Date: Oct 1, 2018 EST...
Pharma / Biotech

AMNESTEEM (Isotretinoin) Capsule [Mylan Pharmaceuticals Inc.]

Newsemia
Updated Date: Sep 27, 2018 EST...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World